Share Price:

APNASPENAspen Pharmacare Hldgs14869165 (1.12%)

Aspen is in a closed period from 1st July 2026 until the publication of the annual results on the JSE SENS platform on the 2nd September 2026.

Aspen champions local manufacturing at the 2026 Manufacturing Indaba

In July, our Group Senior Executive: Strategic Trade, Stavros Nicolaou, represented Aspen at the 2026 Manufacturing Indaba, one of Africa’s leading platforms for advancing industrial growth, localisation and manufacturing-led economic development. This year, there was a particular focus on establishing domestic and regional pharmaceutical value chains for export led growth into the African continent in line with the African Union's ambition to produce 60% of Africa's pharmaceutical requirements in Africa by 2040.
SM Post - OAO Landscape - Stavros - Mining Indaba SM Post 2026

Held at the Sandton Convention Centre in Johannesburg, South Africa, from 14 to 15 July 2026, the Indaba brought together government leaders, policymakers, investors, manufacturers and industry experts under the theme “Scaling Growth, Shaping Trade”. Together, they explored how Africa can strengthen local production, build more resilient supply chains and unlock new opportunities for regional trade.


As a respected industry voice, Stavros shared insights on the importance of growing local pharmaceutical manufacturing and strengthening Africa’s healthcare supply chains. His participation highlighted Aspen’s ongoing commitment to supporting industrial development, improving access to medicines and building sustainable manufacturing capacity across the continent.

During the Indaba, Stavros also joined CNBC Africa to reflect on the urgent need to strengthen South Africa’s manufacturing base. He spoke about the important role that public procurement can play in supporting local manufacturers, building scale, improving competitiveness and opening doors for emerging industrialists.


He also touched on some of the challenges facing manufacturers, including high logistics costs, inefficiencies in ports, rail and harbours, the cost of capital, bureaucracy and red tape. While there is growing support for manufacturing, Stavros emphasised that faster action and stronger execution are needed to help the sector grow and thrive.


Click here to watch Stavros’ full interview. 


For Aspen, the Indaba was an important opportunity to be part of conversations that matter for the future of our industry, our country and our continent. As Africa’s largest pharmaceutical manufacturer, Aspen continues to demonstrate the value of local production, collaboration and investment in high-quality manufacturing capability.

Facebook
Twitter
LinkedIn

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: